Quality Project to Evaluate and Validate the FAST-O Rating Scale

Fluoxetine vs Aripiprazole Comparative Trial (FACT)

NCT02357849 ·Status: TERMINATED ·Phase: PHASE4

Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis

NCT01878513 ·Status: COMPLETED ·Phase: NA

Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia

NCT03230864 ·Status: TERMINATED ·Phase: PHASE3

A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol

NCT00253162 ·Status: COMPLETED ·Phase: PHASE3

KvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment

NCT00750776 ·Status: TERMINATED

Relative Effectiveness of Schizophrenia Therapy Study

NCT01245348 ·Status: COMPLETED

Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations

NCT01181960 ·Status: COMPLETED

Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose

NCT00660595 ·Status: TERMINATED ·Phase: PHASE3

The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine

NCT05213143 ·Status: TERMINATED ·Phase: PHASE4

Typical Versus Atypical Antipsychotics; Occupation of Striatal Receptors and the Appearance of Extrapyramidal Symptomatology, in Healthy Volunteers

NCT01259973 ·Status: UNKNOWN ·Phase: PHASE1

Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia

NCT02717195 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia

NCT01559272 ·Status: COMPLETED ·Phase: PHASE1

Optimization of Acute Treatment in First Episode Schizophrenia

NCT00157378 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy of Lu 31-130 in Patients With Schizophrenia

NCT00770744 ·Status: COMPLETED ·Phase: PHASE2

A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform

NCT02431702 ·Status: COMPLETED ·Phase: PHASE3

Long-Term Study of MP-214 in Patients With Schizophrenia

NCT01626872 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia

NCT02192723 ·Status: COMPLETED ·Phase: NA

A Study for Schizophrenia Relapse Prediction

NCT03629951 ·Status: COMPLETED

Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia

NCT00641745 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication

NCT03557931 ·Status: COMPLETED ·Phase: PHASE2

Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)

NCT00246194 ·Status: COMPLETED

Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)

NCT00147394 ·Status: COMPLETED ·Phase: PHASE1

Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative Symptoms

NCT03929497 ·Status: TERMINATED ·Phase: PHASE2

A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients

NCT00392743 ·Status: COMPLETED

Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in Spain

NCT03130478 ·Status: COMPLETED